Monday, February 5, 2018

Drugs Sold in India Pose a Global Threat to Antibiotic Resistance Control

Millions of unapproved antibiotics are being sold in India each year, according to a new study published in the British Journal of Clinical Pharmacology. The study also revealed that multinational pharmaceutical companies continue to manufacture dozens of unapproved formulations, despite the global health crisis of rising antimicrobial resistance.

There were 118 different formulations of FDCs being sold in India between 2007 and 2012, compared with 5 in the United Kingdom and the United States. 

The researchers argue that changes are needed to achieve the proper use of antibiotics set by the World Health Organization (WHO). 
 
Full citation: "Threats to global antimicrobial resistance control: Centrally approved and unapproved antibiotic formulations sold in India.” Patricia McGettigan, Peter Roderick, Abhay Kadam, and Allyson Pollock. British Journal of Clinical Pharmacology. Published Online: February 5, 2018, DOI: 10.1111/bcp.13503.

No comments: